Is diabetes being overtreated in nursing home residents?

Older adults with diabetes who are living in nursing homes are at high risk of having low blood sugar levels—called hypoglycemia—if their diabetes is overtreated. A study published in the Journal of the American Geriatrics Society suggests that many nursing home residents continue to receive insulin and other medications that increase hypoglycemia risk even after blood tests suggest overtreatment.

Among 7,422 Veterans Affairs nursing home residents, most had blood test results at the start of the study suggesting tight control of their blood sugar levels, and most were on insulin. Only 27% of overtreated and 19% of potentially overtreated residents had their blood sugar–lowering medications appropriately adjusted within 2 weeks.

“I hope this work lays the foundation for future projects that promote appropriate deintensification of glucose lowering medications in nursing home residents,” said lead author Lauren I. Lederle, MD, of the San Francisco VA Medical Center.

URL Upon Publication: https://onlinelibrary.wiley.com/doi/10.1111/jgs.17735

Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact:

Dawn Peters +1 781-388-8408 (US)
newsroom@wiley.com
Follow us on Twitter @WileyNews

About the Journal

Journal of the American Geriatrics Society (JAGS) is the go-to journal for clinical aging research. We provide a diverse, interprofessional community of healthcare professionals with the latest insights on geriatrics education, clinical practice, and public policy—all supporting the high-quality, person-centered care essential to our well-being as we age. 

About Wiley

Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at  Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.